BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to L3.6pl cell line is 458
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CD24 | 1645 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by IF staining and Western Blotting | NA | 0.52 | 0.456 | 32457900 |
| CD24 | 1645 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | Western Blotting followed by FACs and SFA | NA | 0.52 | 0.456 | 28775772 |
| CD24 | 1645 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | qRT-PCR | NA | 0.52 | 0.456 | 26035122 |
| CD24 | 1645 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.456 | 26840266 |
| CD24 | 1645 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | Cisplatin | FACs | NA | 0.52 | 0.456 | 34123574 |
| CD24 | 1645 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | Gemcitabine | FACs | NA | 0.52 | 0.456 | 34123574 |
| CD24 | 1645 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | 5-Fluorouracil | SP assay followed by Tumorigenicity assay and FACs | NA | 0.52 | 0.456 | 24950733 |
| CD24 | 1645 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | Gemcitabine | SP assay followed by Tumorigenicity assay and FACs | NA | 0.52 | 0.456 | 24950733 |
| SOX2 | 11195 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by IF staining and Western Blotting | NA | 0.52 | 0.5695 | 32457900 |
| SOX2 | 11195 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.52 | 0.5695 | 23917223 |
| SOX2 | 11195 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.5695 | 26840266 |
| EPCAM | 11529 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | Western Blotting followed by FACs and SFA | NA | 0.4 | 0.211 | 28775772 |
| EPCAM | 11529 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by qRT-PCR and FACs | NA | 0.4 | 0.211 | 23917223 |
| EPCAM | 11529 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by qRT-PCR | NA | 0.4 | 0.211 | 26840266 |
| CD44 | 1681 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by qRT-PCR and FACs | NA | 0.32 | 1 | 23917223 |
| CD44 | 1681 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | Gemcitabine | qRT-PCR | NA | 0.32 | 1 | 26035122 |
| CD44 | 1681 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | qRT-PCR | NA | 0.32 | 1 | 26035122 |
| CD44 | 1681 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by qRT-PCR | NA | 0.32 | 1 | 26840266 |
| CD44 | 1681 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | Cisplatin | FACs | NA | 0.32 | 1 | 34123574 |
| CD44 | 1681 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | Gemcitabine | FACs | NA | 0.32 | 1 | 34123574 |
| ALDH3A1 | 405 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.28 | 0.0074 | 32503348 |
| ARPC3 | 706 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.28 | 0.0021 | 32503348 |
| CD9 | 1709 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.28 | 0.0032 | 32503348 |
| CTSD | 2529 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.28 | 0.0053 | 32503348 |
| LGALS3BP | 6564 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.28 | 0.0042 | 32503348 |
| NDRG1 | 7679 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.28 | 0.0064 | 32503348 |
| S100A8 | 10498 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.28 | 0.0064 | 32503348 |
| S100A9 | 10499 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.28 | 0.0042 | 32503348 |
| ALDH3A1 | 405 | HTM/LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics and qRT-PCR | Up | 0.28 | 0.0074 | 32503348 |
| ARPC3 | 706 | HTM/LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics and qRT-PCR | Up | 0.28 | 0.0021 | 32503348 |
| CD9 | 1709 | HTM/LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics and qRT-PCR | Up | 0.28 | 0.0032 | 32503348 |
| CTSD | 2529 | HTM/LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics and qRT-PCR | Up | 0.28 | 0.0053 | 32503348 |
| LGALS3BP | 6564 | HTM/LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics and qRT-PCR | Up | 0.28 | 0.0042 | 32503348 |
| NDRG1 | 7679 | HTM/LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics and qRT-PCR | Up | 0.28 | 0.0064 | 32503348 |
| S100A8 | 10498 | HTM/LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics and qRT-PCR | Up | 0.28 | 0.0064 | 32503348 |
| S100A9 | 10499 | HTM/LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics and qRT-PCR | Up | 0.28 | 0.0042 | 32503348 |
| ALDH1A1 | 402 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | qRT-PCR | NA | 0.2 | 0.684 | 26035122 |
| ALDH1A1 | 402 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.684 | 23917223 |
| ALDH1A1 | 402 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | ALDEFLUOR assay followed by SFA and Migration assay | NA | 0.2 | 0.684 | 32004866 |
| ALDH1A1 | 402 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | FACs followed by SFA and Tumorigenicity assay | NA | 0.2 | 0.684 | 21695188 |
| BMI1 | 1066 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.1135 | 26840266 |
| LGR5 | 4504 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0753 | 26840266 |
| MET | 7029 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | qRT-PCR | NA | 0.2 | 0.0191 | 26035122 |
| MYC | 7553 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.1304 | 26840266 |
| NANOG | 20857 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5461 | 26840266 |
| POU5F1 | 9221 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.6448 | 26840266 |
| PROM1 | 9454 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | qRT-PCR | NA | 0.2 | 0.7582 | 26035122 |
| PROM1 | 9454 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.7582 | 23917223 |
| PROM1 | 9454 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | FACs followed by SFA | NA | 0.2 | 0.7582 | 26840266 |
| PROM1 | 9454 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | FACs followed by Tumorigenicity assay and SFA | NA | 0.2 | 0.7582 | 18371365 |
| ABCG2 | 74 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | Cisplatin | FACs | NA | 0.12 | 0.1739 | 34123574 |
| ABCG2 | 74 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | Gemcitabine | FACs | NA | 0.12 | 0.1739 | 34123574 |
| ABCG2 | 74 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | Gemcitabine | SP assay followed by Tumorigenicity assay and FACs | NA | 0.12 | 0.1739 | 24950733 |
| ERBB2 | 3430 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | Cisplatin | FACs | NA | 0.12 | 0.0074 | 34123574 |
| ERBB2 | 3430 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | Gemcitabine | FACs | NA | 0.12 | 0.0074 | 34123574 |
| FUT4 | 4015 | LTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | FACs followed by SFA | NA | 0.12 | 0.0085 | 26840266 |
| AARS1 | 20 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| ABHD14B | 28235 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| ACAT2 | 94 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| ACO2 | 118 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| ACSL3 | 3570 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| ACTR1A | 167 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| ACTR3 | 170 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| AGR2 | 328 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0064 | 32503348 |
| AK1 | 361 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| ALDH1A3 | 409 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0201 | 32503348 |
| ALDH3A2 | 403 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| ALDH7A1 | 877 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| ANP32E | 16673 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| ANXA6 | 544 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 32503348 |
| AP2M1 | 564 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| APEX1 | 587 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| APMAP | 13238 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| APRT | 626 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| ASS1 | 758 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| ATP1A1 | 799 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| ATP1B1 | 804 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| ATP1B3 | 806 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| ATP5F1A | 823 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| B2M | 914 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| BAIAP2 | 947 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| BCAM | 6722 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| BCAP31 | 16695 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| BCLAF1 | 16863 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| BOLA2 | 29488 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| BPIFB1 | 16108 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| C11orf54 | 30204 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0053 | 32503348 |
| C1QBP | 1243 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| CACYBP | 30423 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| CALR | 1455 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| CANX | 1473 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| CAPNS1 | 1481 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| CAST | 1515 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| CAVIN1 | 9688 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| CBX3 | 1553 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| CCDC47 | 24856 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| CCT2 | 1615 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| CCT3 | 1616 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| CCT4 | 1617 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| CCT5 | 1618 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| CCT6A | 1620 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| CCT7 | 1622 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| CD55 | 2665 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| CDC37 | 1735 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| CDC42 | 1736 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| CFL1 | 1874 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| CKB | 1991 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| CLTC | 2092 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| CMPK1 | 18170 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| COPA | 2230 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| COPE | 2234 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| COX4I1 | 2265 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| COX5A | 2267 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| COX7A2 | 2288 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| CPS1 | 2323 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0053 | 32503348 |
| CPSF7 | 30098 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| CSTB | 2482 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| CTNND1 | 2515 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| CTTN | 3338 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| CUTA | 21101 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| CYB5B | 24374 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| DBI | 2690 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| DDX39B | 13917 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| DDX5 | 2746 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| DHX9 | 2750 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 32503348 |
| DIAPH1 | 2876 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| DMBT1 | 2926 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| DNAJB11 | 14889 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| DUT | 3078 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| DYNLL1 | 15476 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| ECH1 | 3149 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| EEF1B2 | 3208 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| EEF1D | 3211 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| EEF1G | 3213 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| EEF2 | 3214 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 32503348 |
| EF1A1P5 | 3200 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| EIF3A | 3271 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| EIF3D | 3278 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| EIF3F | 3275 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| EIF3H | 3273 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| EIF4A1 | 3282 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| EIF4G1 | 3296 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| EIF4H | 12741 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| EIF5 | 3299 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| EIF5A | 3300 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| ELOB | 11619 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| ENO2 | 3353 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| EPHX1 | 3401 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| ERO1A | 13280 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| ERP29 | 13799 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| ERP44 | 18311 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| ETFB | 3482 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| EZR | 12691 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0064 | 32503348 |
| FABP5 | 3560 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| FAF2 | 24666 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| FASN | 3594 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0074 | 32503348 |
| FBL | 3599 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| FDPS | 3631 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| FH | 3700 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| FKBP2 | 3718 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| FLNA | 3754 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| FLOT1 | 3757 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| FLOT2 | 3758 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| FSCN1 | 11148 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0064 | 32503348 |
| FTH1 | 3976 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| FUBP1 | 4004 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| G3BP1 | 30292 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| G6PD | 4057 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| GANAB | 4138 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| GART | 4163 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0064 | 32503348 |
| GATD3A | 1273 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| GCN1 | 4199 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| GDI2 | 4227 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| GLO1 | 4323 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| GMPS | 4378 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| GOT1 | 4432 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| GPI | 4458 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| GRSF1 | 4610 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| GSS | 4624 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| GSTO1 | 13312 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| GSTP1 | 4638 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0053 | 32503348 |
| H1-0 | 4714 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| H1-2 | 4716 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 32503348 |
| H1-5 | 4719 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| HADHA | 4801 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| HADHB | 4803 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| HDGF | 4856 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| HLA-A | 4931 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| HMBS | 4982 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| HMGA1 | 5010 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| HMGB1 | 4983 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| HNRNPA1 | 5031 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| HNRNPA2B1 | 5033 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| HNRNPA3 | 24941 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| HNRNPAB | 5034 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| HNRNPDL | 5037 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| HNRNPF | 5039 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| HNRNPM | 5046 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| HP1BP3 | 24973 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| HSD17B12 | 18646 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| HSP90AA1 | 5253 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0064 | 32503348 |
| HSP90AB1 | 5258 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0074 | 32503348 |
| HSP90AB2P | 32537 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| HSP90B1 | 12028 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| HSPA1B | 5233 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| HSPA4 | 5237 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| HSPA5 | 5238 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0117 | 32503348 |
| HSPA6 | 5239 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 32503348 |
| HSPA8 | 5241 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0085 | 32503348 |
| HSPB1 | 5246 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0053 | 32503348 |
| HSPD1 | 5261 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0064 | 32503348 |
| HSPE1 | 5269 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 32503348 |
| HYOU1 | 16931 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| IDH1 | 5382 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| IFI16 | 5395 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| IMPDH2 | 6053 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| IQGAP1 | 6110 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| IRF6 | 6121 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| ITGA2 | 6137 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0106 | 32503348 |
| ITGB1 | 6153 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.018 | 32503348 |
| JUP | 6207 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| KHSRP | 6316 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| KPNB1 | 6400 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| KRT18 | 6430 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0074 | 32503348 |
| KYNU | 6469 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| LAMP2 | 6501 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| LDHB | 6541 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| LMNA | 6636 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| LRPPRC | 15714 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0064 | 32503348 |
| LTA4H | 6710 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| MACsROH2A1 | 4740 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| MAP4 | 6862 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| MAT2A | 6904 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| MAT2B | 6905 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| MATR3 | 6912 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| MCM3 | 6945 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| MCM4 | 6947 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| MCTS1 | 23357 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| MDH1 | 6970 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 32503348 |
| MIF | 7097 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| MOGS | 24862 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| MPI | 7216 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| MRPL12 | 10378 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| MTHFD1 | 7432 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| MUC4 | 7514 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| MVP | 7531 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| MX1 | 7532 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| MYH9 | 7579 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0064 | 32503348 |
| MYL12A | 16701 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| MYL6 | 7587 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| NANS | 19237 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| NAP1L1 | 7637 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| NASP | 7644 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| NCL | 7667 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| NDUFA5 | 7688 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| NDUFAB1 | 7694 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| NIBAN2 | 25282 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| NME2 | 7850 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| NPEPPS | 7900 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| NPM1 | 7910 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| NSUN2 | 25994 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| NUCKS1 | 29923 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| OAT | 8091 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| OLA1 | 28833 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| P4HA1 | 8546 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| P4HB | 8548 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| PA2G4 | 8550 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| PABPC1 | 8554 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| PABPN1 | 8565 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| PAFAH1B2 | 8575 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| PAICS | 8587 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| PARP1 | 270 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| PCBP1 | 8647 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| PCDHA7 | 8673 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| PDIA3 | 4606 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| PDIA4 | 30167 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0053 | 32503348 |
| PDIA6 | 30168 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| PEBP1 | 8630 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| PFN1 | 8881 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| PFN2 | 8882 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| PGD | 8891 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0053 | 32503348 |
| PGK1 | 8896 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| PGK2 | 8898 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| PGLS | 8903 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| PGM1 | 8905 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| PGRMC1 | 16090 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| PICALM | 15514 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| PKM | 9021 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| PLAT | 9051 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0064 | 32503348 |
| PLEC | 9069 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0053 | 32503348 |
| PLPBP | 9457 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| PPIB | 9255 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| PRDX1 | 9352 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| PRDX2 | 9353 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0074 | 32503348 |
| PRDX5 | 9355 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| PRDX6 | 16753 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| PRKCSH | 9411 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| PRPF19 | 17896 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| PRXL2A | 28651 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| PSMA1 | 9530 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| PSMA2 | 9531 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| PSMA4 | 9533 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| PSMA5 | 9534 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| PSMA7 | 9536 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| PSMB7 | 9544 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| PSMC4 | 9551 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| PSMD14 | 16889 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| PSMD2 | 9559 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| PSME1 | 9568 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| PTGES3 | 16049 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| PTMA | 9623 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| PTMS | 9629 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| PUF60 | 17042 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| PYCARD | 16608 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RAB10 | 9759 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| RAB1A | 9758 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| RAB7A | 9788 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| RACK1 | 4399 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| RAD23B | 9813 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| RAN | 9846 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| RANBP1 | 9847 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RAP1A | 9855 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| RARS1 | 9870 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RBBP7 | 9890 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RCN1 | 9934 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| RPL10 | 10298 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| RPL10A | 10299 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RPL13A | 10304 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 32503348 |
| RPL14 | 10305 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RPL17 | 10307 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RPL18 | 10310 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RPL22 | 10315 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RPL23 | 10316 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| RPL23A | 10317 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| RPL24 | 10325 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RPL27A | 10329 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| RPL29 | 10331 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RPL30 | 10333 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| RPL32 | 10336 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RPL34 | 10340 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| RPL36 | 13631 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| RPL38 | 10349 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| RPL6 | 10362 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| RPL7 | 10363 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| RPL7A | 10364 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RPL8 | 10368 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RPL9 | 10369 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| RPLP0 | 10371 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| RPLP1 | 10372 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RPLP2 | 10377 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RPN1 | 10381 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| RPS10 | 10383 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RPS11 | 10384 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RPS12 | 10385 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| RPS13 | 10386 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RPS14 | 10387 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RPS15 | 10388 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| RPS15A | 10389 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| RPS17 | 10397 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RPS18 | 10401 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| RPS19 | 10402 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RPS2 | 10404 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| RPS20 | 10405 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| RPS25 | 10413 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| RPS26 | 10414 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RPS28 | 10418 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RPS3 | 10420 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| RPS3A | 10421 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| RPS4X | 10424 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| RPS5 | 10426 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| RPS7 | 10440 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| RPSA | 6502 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 32503348 |
| RRBP1 | 10448 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| RTCB | 26935 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| RTRAF | 23169 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| RUVBL1 | 10474 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| S100A11 | 10488 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| S100A16 | 20441 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| S100A6 | 10496 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0053 | 32503348 |
| S100P | 10504 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0106 | 32503348 |
| SCML4 | 21397 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| SCRN1 | 22192 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| SDF2 | 10675 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| SEPTIN2 | 7729 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| SEPTIN9 | 7323 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| SERPINB1 | 3311 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| SERPINB3 | 10569 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0053 | 32503348 |
| SERPINH1 | 1546 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| SF3B1 | 10768 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| SFPQ | 10774 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| SH3BGRL | 10823 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| SKP1 | 10899 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| SLC25A5 | 10991 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| SLC25A6 | 10992 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| SLC2A1 | 11005 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| SLC3A2 | 11026 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0085 | 32503348 |
| SNRNP200 | 30859 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| SNRPA | 11151 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| SNRPD2 | 11159 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| SNRPD3 | 11160 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| SOD1 | 11179 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| SOD2 | 11180 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0064 | 32503348 |
| SPRR3 | 11268 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| SRP14 | 11299 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| SRSF2 | 10783 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| SSR1 | 11323 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| STIP1 | 11387 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| STMN1 | 6510 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| STOML2 | 14559 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| SULT1A2 | 11454 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| SYNCRIP | 16918 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 32503348 |
| TAF15 | 11547 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| TAGLN2 | 11554 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| TALDO1 | 11559 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| TARDBP | 11571 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| TBCA | 11579 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| TCP1 | 11655 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 32503348 |
| TFRC | 11763 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0053 | 32503348 |
| TKFC | 24552 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| TKT | 11834 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0053 | 32503348 |
| TMEM214 | 25983 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| TMPO | 11875 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| TOMM20 | 20947 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| TOP1 | 11986 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| TPD52L2 | 12007 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| TPI1 | 12009 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| TPT1 | 12022 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| TRAP1 | 16264 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0053 | 32503348 |
| TRIM28 | 16384 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| TRIM29 | 17274 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0074 | 32503348 |
| TST | 12388 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| TTLL12 | 28974 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| TUBA1A | 20766 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| TUBA1B | 18809 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| TUBA1C | 20768 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| TUBB | 20778 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| TUBB4B | 20771 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| TUBB8 | 20773 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| TUFM | 12420 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 32503348 |
| TXN | 12435 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 32503348 |
| UBA1 | 12469 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| UBA52 | 12458 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| UBE2L3 | 12488 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| UGP2 | 12527 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| USP5 | 12628 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| UTS2 | 12636 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 32503348 |
| VAPA | 12648 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| VARS1 | 12651 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 32503348 |
| VAT1 | 16919 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 32503348 |
| VCP | 12666 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |
| VIM | 12692 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.017 | 32503348 |
| WARS1 | 12729 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| XPO1 | 12825 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| XRCC5 | 12833 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| XRCC6 | 4055 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 32503348 |
| YWHAG | 12852 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 32503348 |
| YWHAQ | 12854 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 32503348 |
| YWHAZ | 12855 | HTM | Pancreatic Cancer | Adenosquamous Cell Carcinoma | L3.6pl | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 32503348 |